XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity and Stock-Based Compensation
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders’ Equity and Stock-Based Compensation STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION
The Company includes stock compensation expense within general and administrative expenses in the Condensed Consolidated Statements of Operations. During the three months ended March 31, 2023 and 2022, the Company recognized $0.6 million and $0.5 million of stock compensation expense, respectively.
The Company has a long term incentive plan (the “Amended and Restated Plan”) which provides for a maximum number of shares of common stock available for issuance of 4,000,000 shares. Awards under the Amended and Restated Plan may be granted to employees, officers and directors of the Company and affiliates, and any other person who provides services to the Company and its affiliates (including independent contractors and consultants of the Company and its subsidiaries). Awards may be granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalents, substitute awards, other stock-based awards, cash awards and/or any combination of the foregoing. No participant may receive a grant covering more than 2,000,000 shares of our common stock in any year and a non-employee member of the Board may not be granted more than 100,000 shares in any year.
Issuances of Common Stock
During the three months ended March 31, 2023, and 2022, shares of common stock were issued upon vesting of restricted stock units of 13,587 and 501,334, respectively. There were no stock options exercised during the three months ended March 31, 2023 or 2022.